Anti-TNF Receptor II抗体(ab15563)

ab15563 被引用在 11 文献中.

• Kim JE  et al. Status Epilepticus Induces Vasogenic Edema via Tumor Necrosis Factor-a/ Endothelin-1-Mediated Two Different Pathways. PLoS One 8:e74458 (2013). WB, ICC/IF ; Rat . PubMed: 24040253
• Al-Zoubi M  et al. Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFa completely prevents breast cancer tumor formation in vivo. Cell Cycle 12:480-90 (2013). PubMed: 23292149
• Weinberg MS  et al. Opposing actions of hippocampus TNFa receptors on limbic seizure susceptibility. Exp Neurol 247:429-37 (2013). PubMed: 23333565
• Maddahi A  et al. Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway. J Neuroinflammation 9:274 (2012). IHC . PubMed: 23259581
• Hosono K  et al. Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas. World J Gastroenterol 18:5360-8 (2012). IHC-P ; Human . PubMed: 23082052
• Maddahi A  et al. The role of tumor necrosis factor-a and TNF-a receptors in cerebral arteries following cerebral ischemia in rat. J Neuroinflammation 8:107 (2011). IHC . PubMed: 21871121
• Sakumoto R  et al. Localization of gene and protein expressions of tumor necrosis factor-{alpha} and tumor necrosis factor receptor types I and II in the bovine corpus luteum during the estrous cycle. J Anim Sci 89:3040-7 (2011). PubMed: 21551345
• Jiang B  et al. Neuroinflammation in advanced canine glaucoma. Mol Vis 16:2092-108 (2010). IHC-P ; Dog . PubMed: 21042562
• Okuda K  et al. Cellular localization of genes and proteins for tumor necrosis factor-a (TNF), TNF receptor types I and II in bovine endometrium. Mol Cell Endocrinol 330:41-8 (2010). IHC-P . PubMed: 20705117
• Khan AA  et al. Tumor necrosis factor alpha enhances the sensitivity of rat trigeminal neurons to capsaicin. Neuroscience 155:503-9 (2008). PubMed: 18582539
• Harrison ML  et al. Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose. J Clin Oncol 25:4542-9 (2007). PubMed: 17925549